Ecto-5'-nucleotidase (ecto-5'-NT) is believed to be a maturation marker for human B lymphocytes because its expression increases during normal development and is reduced in many patients with B cell immunodeficiencies. To determine whether this enzyme defines functional subsets of B lymphocytes, human peripheral blood B cells, separated into ecto-5'-NT positive and negative populations by using goat anti-5'-NT antibodies and the fluorescence-activated cell sorter, were compared for their ability to secrete polyclonal immunoglobulin. Both populations synthesized equivalent quantities of IgM in response to a T cell-dependent (PWM) or T cell-independent (EBV) stimulator of polyclonal immunoglobulin biosynthesis. However' ecto-5'-NT+ B lymphocytes synthesized 8-to 26-fold more IgG per cell than ecto-5'-NT-B cells. These data provide the first direct evidence that ecto-5'-NT is a marker for the functional maturation of human B cells and support the hypothesis that ecto-5'-NT deficiency in patients with hypogammaglobulinemia results from a block in B lymphocyte maturation.
Introduction
Ecto-5'-nucleotidase (ecto-5'-NT)' is an enzyme located on the external surface of the majority of adult human peripheral blood B cells (1, 2) . This enzyme is thought to be a B lymphocyte maturation marker (3, 4) , because its expression increases during B cell development. Ecto-5'-NT activity in fetal spleen and cord blood B cells is about one-fifth that in adult peripheral blood B cells (1, 3, 4) . Cord blood B cells are functionally immature in that they can synthesize only IgM (but not IgG) after stimulation in vitro with EBV (5) . Ecto-5'-NT activity increases to near adult levels during the first six months of life 1 . Abbreviations used in this paper: BBS, borate-buffered saline; CVI, common variable immunodeficiency; ecto-5'-NT, ecto-5'-nucleotidase; EN, neuraminadase-treated sheep erythrocytes; FITC, fluorescein isothiocyanate; PE, phycoerythrin. (6) . This increase in enzyme activity precedes the time that infants' B cells mature and acquire the ability to synthesize IgG in vitro in response to EBV. The ecto-5'-NT activity in B cells from many patients with common variable immunodeficiency (CVI) is also markedly reduced (1, 4) , and although such patients can occasionally synthesize some IgM in response to PWM or EBV, they uniformly fail to synthesize IgG (reference 1 and Thompson, L. F., unpublished observations).
We recently described the use of specific goat antibodies to detect cell surface 5'-NT by indirect immunofluorescence (2, 7). As was previously found by histochemical staining (1), ecto-5'-NT is expressed on 80% of adult peripheral blood B cells. To determine whether ecto-5'-NT expression defines functional subpopulations of human B cells, we used our antibodies to isolate highly purified ecto-5'-NT positive and negative B cell preparations. These cells were then treated with both a T cell-dependent (PWM) and a T cell-independent (EBV) stimulator of polyclonal Ig biosynthesis, and the quantities of IgM and IgG secreted were determined.
Methods
Cell isolation. PBL were isolated from heparinized blood of healthy adult donors by dextran sedimentation, carbonyl iron treatment to remove monocytes, and Ficoll-Hypaque density gradient centrifugation. T cells were isolated by one cycle of rosetting with neuraminidase-treated sheep erythrocytes, EN, followed by Ficoll-Hypaque density gradient centrifugation. EN were lysed with 0.83% NH4Cl. Non-T (B-enriched) cells were isolated at the interface of the second FicollHypaque gradient (8) . Monocytes were isolated from PBMC at the interface between 0 and 50% Percoll on a discontinuous gradient (9) . These preparations contained > 80% monocytes as judged by nonspecific esterase staining (10) .
Preparation ofthe antiserum, immunofluorescence, and cell sorting. The anti-5'-NT antiserum was prepared by immunizing a goat with highly purified human placental 5'-NT and absorbed as previously described (7) . IgG was isolated by precipitation with 50% saturated ammonium sulfate and DEAE cellulose chromatography. The IgG eluting at 0.0 15 M phosphate, pH 8.0, was digested with pepsin at pH 3.8 to produce F(ab')2 fragments. To detect cell surface 5'-NT, lymphocytes were incubated with F(ab')2 anti-5'-NT at 250 ,g/ml followed by affinity-purified F(ab')2 rabbit anti-goat IgG, which had been absorbed on a Cohn II-Sepharose column and then biotinylated (CooperBiomedical, Malvern, PA), and fluorescein isothiocyanate (FITC) avidin (CooperBiomedical) (7) . For two-color sorts, the cells were also stained with Leu 12 The stained cells were separated into Fl+ and F1-populations using the FACSTAR fluorescence-activated cell sorter (Becton, Dickinson & View, CA). FITC and PE were excited at 488 nm and their fluorescent emissions were distinguished with 530±15-and 575±14-nm band pass filters. The overlap in emissions of FITC and PE was corrected by electronic compensation. The sorting gates were chosen so that the positive and negative populations were > 95% pure when reanalyzed. After being sorted, the cells were > 97% viable as determined by trypan blue dye exclusion.
PWM stimulation. 500,000 non-T (B-enriched) cells, 500,000 autologous irradiated (3,000 rads) T cells, and 104 monocytes were incubated in the presence and absence of PWM (1:50 final dilution in culture; Gibco Laboratories, Grand Island, NY) in round-bottomed tubes in a total volume of 1.0 ml of RPMI 1640 + 10% FCS. After 7 d at 370C in an humidified atmosphere of 95% air and 5% C02, the cells were centrifuged and the supernatants were collected for quantitation of IgM and IgG secreted. In some experiments, the volume of the cultures was reduced to 0.5 ml, but the cell concentrations remained constant.
EBV stimulation. 500,000 non-T (B-enriched) cells and 104 monocytes were incubated in the presence and absence of 20% (vol/vol) EBV-containing supernatant from B 95-8 cells in round-bottomed tubes in a total volume of 1.0 ml of RPMI 1640 + 10% FCS. After 10 d at 370C in an humidified atmosphere of 95% air and 5% C02, the cells were centrifuged and the supernatants were collected for quantitation of IgM and IgG secreted. In some experiments, the volume of the cultures was reduced to 0.5 ml, but the cell concentrations remained were then added to wells (100 Ml/well) and incubated overnight at 4°C.
After five washes with Blotto, the wells were incubated with 100 Ml of alkaline phosphatase-conjugated affinity purified goat anti-human Ig (Tago, Inc., Burlingame, CA) for 3 h at 37°C. After five more washes with Blotto, the wells were treated with 100 Ml of p-nitrophenylphosphate (Sigma Chemical Co., 1 mg/ml in 0.1 M glycine, 0.001 M MgCl2, and 0.001 M ZnCl2, pH 9.45). Color development then proceeded for -15-30 min at room temperature, after which the reaction was terminated by the addition of 25 Ml 4 N NaOH/well. Optical density at 405 nm was measured with a microelisa analyzer (Dynatech Laboratories, Inc.). All supernatants were tested at three serial dilutions in duplicate. The standards were the Hyland International Reference Serum for IgM and a Cohn II fraction of human serum for IgG (gift of Dr. Hans Spiegelberg, Scripps Clinic and Research Foundation). The ranges of concentrations included in the standard curves were 250-32,000 pg/ml for IgM and 1,000-125,000 pg/ml for IgG.
Results and Discussion
Non-T (B-enriched) cells were sorted into ecto-5'-NT positive and negative populations and compared for their ability to synthesize polyclonal IgM and IgG in response to PWM or EBV (Table I) (Table II) . In a preliminary examination of this phenomenon, anti-5'-NT antibodies were included in the culture medium during the entire 7-d stimulation of PBMC with PWM. The response varied from donor to donor, but in the five individuals studied, the average enhancement in IgM synthesis in the cultures treated with anti-Y-NT antibodies was 6.5-fold. IgG synthesis also increased 2-fold. These data suggest that ecto-5'-NT may play a direct role in B cell activation. Experiments are now in progress to determine whether the interaction of anti-5'-NT antibodies with B cells triggers known biochemical pathways of B cell activation.
In (5, 6) . Ecto-5'-NT expression increases in the first six months of life (6) and is then maintained in the subset of B cells that is PWM-responsive. Ecto-5'-NT thus differs from other B cell maturation markers such as IgD, HB-4, Leu 8, and the mouse erythrocyte rosette receptor, which are lost as B cells mature and gain the ability to respond to PWM (13) (14) (15) 
